Oxurion NV (OXUR.BR)

EUR 0.09

(4.53%)

Total Liabilities Summary of Oxurion NV

Oxurion NV's latest annual total liabilities in 2023 was 19.73 Million EUR , up 19.06% from previous year.
Oxurion NV's latest quarterly total liabilities in 2024 Q2 was 19.36 Million EUR , down 0.0% from previous quarter.
Oxurion NV reported annual total liabilities of 16.57 Million EUR in 2022, down -17.05% from previous year.
Oxurion NV reported annual total liabilities of 19.98 Million EUR in 2021, up 116.37% from previous year.
Oxurion NV reported quarterly total liabilities of 19.73 Million EUR for 2023 FY, up 19.06% from previous quarter.
Oxurion NV reported quarterly total liabilities of 19.73 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Total Liabilities Chart of Oxurion NV (2023 - 2006)

Historical Annual Total Liabilities of Oxurion NV (2023 - 2006)

Year	Total Liabilities	Total Liabilities Growth
2023	19.73 Million EUR	19.06%
2022	16.57 Million EUR	-17.05%
2021	19.98 Million EUR	116.37%
2020	9.23 Million EUR	-21.22%
2019	11.72 Million EUR	22.71%
2018	9.55 Million EUR	-44.06%
2017	17.08 Million EUR	45.03%
2016	11.77 Million EUR	31.87%
2015	8.93 Million EUR	-29.69%
2014	12.7 Million EUR	2.58%
2013	12.38 Million EUR	10.5%
2012	11.2 Million EUR	1.31%
2011	11.06 Million EUR	132.99%
2010	4.74 Million EUR	-36.72%
2009	7.5 Million EUR	55.95%
2008	4.81 Million EUR	35.04%
2007	3.56 Million EUR	73.25%
2006	2.05 Million EUR	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	19.36 Million EUR	0.0%
2023 FY	19.73 Million EUR	19.06%
2023 Q4	19.73 Million EUR	0.0%
2023 Q2	20.44 Million EUR	0.0%
2022 Q4	16.57 Million EUR	0.0%
2022 Q2	14.36 Million EUR	0.0%
2022 FY	16.57 Million EUR	-17.05%
2021 FY	19.98 Million EUR	116.37%
2021 Q2	9.4 Million EUR	0.0%
2021 Q4	19.98 Million EUR	0.0%
2020 Q4	9.23 Million EUR	0.0%
2020 Q2	8.25 Million EUR	0.0%
2020 FY	9.23 Million EUR	-21.22%
2019 Q2	7.87 Million EUR	0.0%
2019 FY	11.72 Million EUR	22.71%
2019 Q4	11.72 Million EUR	0.0%
2018 Q4	9.55 Million EUR	0.0%
2018 FY	9.55 Million EUR	-44.06%
2018 Q2	6.52 Million EUR	0.0%
2017 Q2	8.3 Million EUR	0.0%
2017 FY	17.08 Million EUR	45.03%
2017 Q4	17.08 Million EUR	0.0%
2016 FY	11.77 Million EUR	31.87%
2016 Q4	11.77 Million EUR	0.0%
2016 Q2	11.36 Million EUR	0.0%
2015 Q2	7.73 Million EUR	0.0%
2015 FY	8.93 Million EUR	-29.69%
2015 Q4	8.93 Million EUR	0.0%
2014 Q2	10.83 Million EUR	0.0%
2014 FY	12.7 Million EUR	2.58%
2014 Q4	12.7 Million EUR	0.0%
2013 Q2	11.6 Million EUR	0.0%
2013 FY	12.38 Million EUR	10.5%
2013 Q4	12.38 Million EUR	0.0%
2012 Q2	8.04 Million EUR	0.0%
2012 FY	11.2 Million EUR	1.31%
2012 Q4	11.2 Million EUR	0.0%
2011 Q2	5.05 Million EUR	0.0%
2011 FY	11.06 Million EUR	132.99%
2011 Q4	11.06 Million EUR	0.0%
2010 FY	4.74 Million EUR	-36.72%
2010 Q4	4.74 Million EUR	0.0%
2010 Q2	5.74 Million EUR	0.0%
2009 FY	7.5 Million EUR	55.95%
2009 Q4	7.5 Million EUR	0.0%
2008 FY	4.81 Million EUR	35.04%
2007 FY	3.56 Million EUR	73.25%
2006 FY	2.05 Million EUR	0.0%

Peer Total Liabilities Comparison of Oxurion NV

Name	Total Liabilities	Total Liabilities Difference
Nicox S.A.	31.56 Million EUR	37.479%
European Medical Solutions	33.86 Million EUR	41.723%
FERMENTALG	19.39 Million EUR	-1.742%
argenx SE	402.79 Million EUR	95.1%
BioSenic S.A.	32.26 Million EUR	38.83%
Celyad Oncology SA	9.97 Million EUR	-97.795%
Hyloris Pharmaceuticals SA	8.61 Million EUR	-129.169%
Onward Medical N.V.	25.69 Million EUR	23.2%
PHAXIAM Therapeutics S.A.	25.69 Million EUR	23.191%
Financière de Tubize SA	123.65 Million EUR	84.039%
UCB SA	6.56 Billion EUR	99.699%